InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Veterans Service Team Announce Launch of ‘Valor CBD’
December 1, 2023
Pressure BioSciences (OTCQB: PBIO) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, and other industries. The company, together with the Veterans Service Team (“VST”), a self-funded, 501(c)(3) non-profit company dedicated to the support and wellness […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q3 2023 Financial Report, Business Update
November 21, 2023
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty-testing services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmeceuticals, agriculture, and food & beverage industries, is reporting company financial results for the third quarter ended Sept. 30, 2023. The company also released a business update and limited […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Discuss Q3 2023 Results, Provide Business Update
November 20, 2023
Pressure BioSciences (OTCQB: PBIO) today announced that it will host a teleconference to discuss its third quarter 2023 financial results and to provide a business update. The teleconference, set to take place at 4:30 p.m. ET on Tuesday, Nov. 21, 2023, will include a company presentation followed by a question and answer period. To attend […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Nano CB ‘Vastly Outperforms Current Technologies,’ According to Independent Study
November 9, 2023
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, agrochemical, and other industries has received “powerful scientific validation” through an independent peer-reviewed scientific study. According to the announcement, globally renowned cannabis/natural products researcher […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) BaroFold Technology Platform Featured at International Bioprocess Conference
November 2, 2023
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide life sciences, nutraceuticals, cosmetics, food and beverage, and other key industries, is collaborating with scientists from Lonza Biologics. According to the announcement, the two companies are working to present convincing […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Exclusive Distribution Agreement with Premier India Distributor in Life Sciences Space
October 18, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has partnered with Bioscreen Instruments PVT LTD through an exclusive instrument and consumables distribution agreement for India. Bioscreen is […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures First Canadian Patent for Revolutionary UltraShear(TM) Platform
October 10, 2023
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and testing services to the global pharmaceuticals, nutraceuticals, cosmeceuticals, food/beverage and other industries. The company today announced the award of the first Canadian patent for its revolutionary UltraShear(TM) Technology (“UltraShear(TM)” or “USTTM”) […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures 10X Increase in Existing VST Purchase Order
September 22, 2023
Pressure BioSciences (OTCQB: PBIO) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, and other industries. PBIO, together with the Veterans Service Team (“VST”) (www.vst.org), a self-funded, 501(c)3 non-profit company dedicated to the support and wellness […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Begins Fulfillment of UltraShear Nano-CBD Orders
September 21, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has completed the initial expansion of its launch-phase manufacturing capacity. In addition, the company has completed a review of […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces ‘Key Transition’ Focused on Sale, Installation, Qualification of BaroFold Manufacturing System
September 8, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide biopharmaceuticals, nutraceuticals, cosmeceuticals, food and beverage, and other industries, is making an adjustment in its business approach. The company has announced “a key transition in its collaborations with multiple leaders […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Progress Report on UltraShear Nano-CBD Launch, Commercialization Program
August 30, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has released an update regarding launch progress and commercialization program for its revolutionary, best-in-class Nano-CBD product; the product is […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Q2 2023 Financial Results, Business Update
August 22, 2023
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biotechnology and other industries, today released financial results for the second quarter ended June 30, 2023, provided a business update, and offered limited guidance for expected achievements through the remainder of […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Hosts Webinar Showcasing Revolutionary UltraShear Platform
August 17, 2023
Pressure BioSciences (OTCQB: PBIO) today announced that its CEO and President Richard T. Schumacher and Director of Marketing and Sales John B. Hollister are the featured speakers at an online webinar scheduled for 11 a.m. ET on Thursday, Aug. 17, 2023. The webinar will showcase an overview of Pressure BioSciences and its core technologies and […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Gratifying ‘Tip of the Iceberg’ Start of Accelerated UltraShear(TM) Nano-CBD Orders
August 9, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide biotherapeutics, nutraceuticals, cosmeceuticals, food and beverage, and other industries, today announced strongly accelerating orders for its UltraShear(TM)-processed Nano-CBD topical spray product. According to the update, the company has received seven […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Significant Increase in UltraShear-Processed Nanoemulsions
July 26, 2023
Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, biotherapeutics, food/beverage, and other industries. The company today announced that Canopy CBD Farms LLC (“CCF”), PBIO’s master distributor for cannabis products in North America, has reported a […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Launches Program to Evaluate UltraShear(TM) Technology to Preserve Quality of Fresh Produce
July 25, 2023
Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide food and beverage, agrochemicals, nutraceuticals and other industries. The company today announced the initiation of studies to evaluate and demonstrate its UltraShear Technology(TM) (“UltraShear(TM)”) platform for producing oil-in-water nanoemulsions […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Phase 2 of Commercialization of Its UltraShear(TM)-Processed Nano-CBD Topical Spray
July 17, 2023
Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, biotherapeutics, food and beverage, and other industries. The company has announced, in an interview with renowned cannabis business authority Jeffrey Friedland, that PBIO is advancing into phase […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Distribution Agreement with CdC for UltraShear Processed Nano-CBD Topical Spray
July 10, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has announced a partnership with Crème de Canna (“CdC”). According to the announcement, the two companies have entered a […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Notes Key Academic Publication Validates Platform’s Impact in Clean-Label Functional Foods & Beverages
July 6, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, is reporting that its UltraShear(TM) Technology platform delivers transformational capabilities that address leading industry and consumer trends in food […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Collaborates for Development and Distribution of UltraShear(TM)-Enhanced Products
July 5, 2023
Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, biotherapeutics, food and beverage, and other industries. The company today announced its entry into an agreement with Somalab International LLC, a Texas-based leading supplier of novel health […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Webinar, Reports on Positive Results from Third Round of Consumer Testing
June 27, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis, and other industries, has scheduled an online webinar today at 4:30 p.m. ET. The webinar will feature PBIO president and CEO Richard […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Inks Agreement to Provide VST Members with UltraShear Nano-CBD, Other Products
June 13, 2023
Pressure BioSciences (OTCQB: PBIO) has entered a development and supply agreement with the Veterans Service Team (“VST”) to provide world-class, highly effective, and natural wellness products to benefit the mind, body and soul. Set to last five years, the long-term agreement offers VST members exclusive access to custom-designed, hemp-derived, UltraShear-processed nanoemulsions of CBD oil in […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to be Featured on New to The Street Series
June 1, 2023
FMW Media’s business TV show, New to The Street, has announced the signing of a 12-month contract for filming and broadcasting tailored interviews and commercials about Pressure BioSciences (OTCQB: PBIO) (“PBI”). According to the announcement, New to The Street’s TV anchors will interview the management team at PBIO with each show airing on its televised […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Achieves Record Financial Results in Q1 2023
May 16, 2023
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide biotherapeutics, nutraceuticals, cosmeceuticals, food and beverage, and other industries. The company today reported record quarterly financial results for any fiscal quarter achieved in the first quarter ended March […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes New Opportunities, Looks to ‘Watershed’ Year as Focus Groups Report Impressive Results
May 10, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products, and specialty services to the life sciences, nutraceuticals, cosmeceuticals and other industries, is reporting on a consumer focus group. The focus group was designed to test a THC Nanoemulsion Oral Spray designed for rapid, direct absorption […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Rapid Progress on Limited Offering of Exclusive THC Licenses for UST(TM) Platform
April 26, 2023
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products and specialty services to the life sciences, nutraceuticals, cosmeceuticals, and other industries, today provided a progress update on its April 21, 2023, announcement. On that day, the company announced its strategic decision to offer up […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Changes to Exclusive UltraShear Nanoemulsion Processing Platform Licenses
April 21, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products, and specialty services to the life sciences, nutraceuticals, cosmeceuticals and other industries, is making changes to its license offerings. The company announced a strategic decision to offer up to five exclusive licenses to its patented and […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Artisan Industries Inc. Enter Strategic Agreement
April 19, 2023
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products and specialty services to the life sciences field, and Artisan Industries, a worldwide leader in providing purification and separation technologies for the process industries, announced a strategic agreement between the companies. Under the agreement, PBIO […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Schedules Conference Call, Announces Q4 and FY 2022 Financial Results, 2023 Guidance
April 14, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences industry, has scheduled a conference call for Tuesday, April 18, 2023; to begin at 4:30 p.m. ET. The focus of the call will be to discuss PBIO’s 2022 financial results and provide […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), NutraLife Biosciences Partner to Develop, Distribute Next-Generation Nutraceuticals
April 6, 2023
Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences industry, has renewed its partnership with NutraLife Biosciences (OTC: NLBS), a highly respected manufacturer and distributor of nutraceuticals primarily sold on a direct-to-consumer basis. The two companies first began working together four […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Growing Demand for Eco-Friendly Agrochem Products
March 28, 2023
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences and other industries. The company, together with its wholly owned subsidiary PBI Agrochem Inc., today announced that it has shipped and billed an initial $130,000 order for its potent, environmentally-responsible […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces $1.5M Order for Proprietary UltraShear Nanoemulsified CBD
March 22, 2023
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide nutraceuticals, cosmetics, biotherapeutics and food/beverage industries, has entered an execution and launch agreement with CBD Supply MD, one of the largest and best-known retail suppliers of CBD products […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Largest Investor Exchanges $10M-Plus Debt into Non-Secured Equity
March 1, 2023
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide nutraceuticals, cosmetics, biotherapeutics and food/beverage industries, announced that its largest shareholder has exchanged more than $10 million of senior secured debt into unsecured preferred stock. According to the […]
InvestorNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UltraShear(TM) Platform Holds Significant Potential in the Edible Cannabis Sector
February 24, 2023
Pressure BioSciences (OTCQB: PBIO) (“PBI”) earlier this month announced potentially ground-breaking results from a consumer focus group testing a THC oral spray developed using the company’s innovative UltraShear(TM) nanoemulsification platform. The spray demonstrated strong potency and extremely fast absorption that could put it on track to become a best-in-class cannabis product in terms of speed […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Record Order, Eyes Strong Commercial Traction for UltraShear Nanoemulsions Technology Platform
February 1, 2023
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences and other industries, today announced entrance into an exclusive distribution agreement for the People’s Republic of China with PRS International Trade (Shanghai) Co., Ltd. Reflecting confidence in PBIO’s long investment in […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), One World Products Inc. (OWPC) Team up to Deliver Sports Performance/Recovery Drinks
January 27, 2023
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences industry, and One World Products (OTCQB: OWPC), the largest Black-controlled, fully-licensed hemp and cannabis producer in Colombia, today announced entry into an active collaboration agreement. Under the agreement, the two companies […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Results of Consumer Focus Group Testing THC Nanoemulsion Oral Spray
January 19, 2023
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide nutraceuticals, cosmetics, biotherapeutics and food/beverage industries, is reporting on a consumer focus group test. The test featured a THC nanoemulsion oral spray featuring PBI’s proprietary Ultra Shear Technology(TM) […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q4 2022 Guidance, Projections for 2023
December 27, 2022
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide nutraceuticals, cosmetics, biotherapeutics and food/beverage industries, is sharing projections for its Q4 2022 revenue. According to the announcement, the company anticipates revenue for the last quarter of 2022 […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Confirms Shipment of Revolutionary Nanoemulsion Product
December 13, 2022
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide nutraceuticals, cosmetics, biotherapeutics and food/beverage industries, has shipped its first-ever commercial production lot of an UltraShear nanoemulsion product. The revolutionary product was created and enabled by PBIO’s Ultra […]
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Potential Q2 2023 Commercial Sales of Dr. Denese SkinScience, UltraShear Nanoemulsion-Enabled Products
December 7, 2022
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and production services to the worldwide cosmetics, nutraceuticals, biotherapeutics, food/beverage, and other industries. The company today confirmed that initial results from its first stage of product development under PBI’s August 2022 collaboration […]